肝癌患者尿液中HCV抗体的检测  

DETECTION OF ANTI-HCV IN URINE OF PATIENTS WITH PRIMARY HEPATOCELLULAR CANCER

作　　者：欧阳学农[1] 陈樟树[1] 戴西湖[1] 范寅根[1] 饶本强[1] 曾金雄[1] 陈曦[1] 

机构地区：[1]南京军区福州总医院肿瘤科

出　　处：《解放军预防医学杂志》1998年第3期172-174,共3页Journal of Preventive Medicine of Chinese People's Liberation Army

摘　　要：为进一步研究丙型肝炎病毒（ＨＣＶ）和原发性肝癌（ＰＨＣ）的关系，采用酶联免疫吸附反应（ＥＬＩＳＡ）平行检测１５２例ＰＨＣ患者尿液及血清中ＨＣＶ抗体（抗－ＨＣＶ）。结果表明，其检出率分别为１３．８２％（２１／１５２）和１４．４７％（２２／１５２）。两种标本抗－ＨＣＶ检测的阳性符合率为９５．４５％，阴性符合率１００％。检测尿液中抗－ＨＣＶ－ＩｇＧ简便易行，安全可靠。提示，ＰＨＣ患者尿液抗－ＨＣＶ－ＩｇＧ的检测，有助于ＰＨＣ病因学。To further study the relationship between hepatitis C virus (HCV) snd primary hepatocellular cancer (PHC), antibody to HCV was examined in sera and urine of 152 patients with PHC. The prevalence of anti-HCV in sera was 14.47%(22/152),and the prevalence of anti-HCV in urine was 13.82% (21/152). The method detecting anti-HCV in urine is simple, safe, and cost saving. It is suggested that detection of anti-HCV in urine may be useful to study the role of HCV in the development of PHC

关 键 词：肝肿瘤 尿液 丙型肝炎病毒 抗体 测定 

分 类 号：R735.7[医药卫生—肿瘤]